Effect of VNS on Gastric Motor Functions
VNS 对胃运动功能的影响
基本信息
- 批准号:10610561
- 负责人:
- 金额:$ 7.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-23 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAdverse effectsAnatomyAutonomic nervous system disordersCardiovascular DiseasesCervicalChronicClinicClinicalClinical ResearchDataDiseaseDyspepsiaElectric StimulationEmergency department visitEpilepsyFDA approvedFaceFastingFatty acid glycerol estersFemaleFoundationsFrequenciesFutureGastric EmptyingGastrointestinal DiseasesGastroparesisGenerationsGoalsHeartHeart failureHigh PrevalenceImageImmune System DiseasesImplantIncidenceInflammationIngestionInsulin-Dependent Diabetes MellitusLeftMeasurementMeasuresMediatingMental DepressionMetabolic DiseasesMethodsMetoclopramideMinnesotaMotorMovementMovement DisordersMuscleNeuronsNitrogenNon-Insulin-Dependent Diabetes MellitusNormal RangeObesityOperative Surgical ProceduresOrganOutpatientsPatientsPeripheralPersonsPharmaceutical PreparationsPhysiologic pulsePlayPopulationPrevalenceProtocols documentationRadiolabeledReportingResearchReview LiteratureRiskRoleSensorySolidStomachSymptomsTardive DyskinesiaTestingTimeUniversitiesVagus nerve structureWidthWorkcholinergiccohortcomorbidityeffective therapyegggastrointestinal symptomhospitalization ratesinnovationinsightintravenous injectionmeetingsmortalitymotor disordernerve supplynovelopen labelpost strokeresponsesingle photon emission computed tomographysleep patternstroke recoverysystematic reviewvagus nerve stimulation
项目摘要
ANCILLARY PROJECT 2 Abstract: Effect of VNS on Gastric Motor Functions
The prevalence of gastroparesis (i.e., inability for the stomach to empty itself normally) ranges from 13.8 to 267.7 per 100,000 adults; in addition, 2.5% are hospitalized each year, with 0.3% mortality. There is no consistently effective treatment for this condition: the only FDA-approved medication, metoclopramide, can only be used for
<12 weeks because of risk of the debilitating movement disorder tardive dyskinesia. To gather key data as a foundation for new gastroparesis treatment, we propose to evaluate the effect of left vagus nerve stimulation (VNS) on gastric emptying and accommodation functions in patients undergoing treatment for depression or epilepsy. Whereas the effects of VNS on other functions such as sleep patterns or heart period responses reflecting cardiovagal innervation have been reported, the effects of such treatment on gastric functions are unknown. It is clear, however, that the vagus nerve provides the extrinsic input to cholinergic intrinsic neurons that stimulate gastric muscle contractility and to the nitrogen-intrinsic neurons that mediate gastric accommodation. Our hypothesis is that cervical VNS increases gastric accommodation and accelerates gastric emptying. Our specific aim is to compare simultaneous assessment of gastric emptying and gastric accommodation in response to the same caloric meal before and three months after activation of left cervical VNS. The functions of the stomach will be measured using validated methods conducted simultaneously using SPECT camera imaging and a radiolabeled meal, with a first measurement of gastric volume during fasting after intravenous injection of pertechnetate and a second measurement of postprandial gastric volume accommodation and gastric emptying following the ingestion of a 320 kilocalorie, 30% fat egg meal. These innovative studies will document the effect of VNS as the foundation for a potential novel treatment for correcting disorders of gastric motor function.
辅助方案2摘要:迷走神经对胃运动功能的影响
胃轻瘫(即胃无法正常排空)的患病率从每100,000人中有13.8%到267.7人不等;此外,每年有2.5%的人住院,死亡率为0.3%。对于这种情况没有一贯有效的治疗方法:FDA批准的唯一药物甲氧氯普胺只能用于
<;12周,因为有患衰弱运动障碍的风险,迟发性运动障碍。为了收集关键数据作为新的胃瘫治疗的基础,我们建议评估左侧迷走神经刺激(VNS)对抑郁症或癫痫治疗患者胃排空和调节功能的影响。虽然VNS对其他功能的影响已有报道,如反映心脏迷走神经支配的睡眠模式或心动周期反应,但此类治疗对胃功能的影响尚不清楚。然而,很明显,迷走神经为刺激胃肌肉收缩的胆碱能内源性神经元和调节胃适应的内源性氮神经元提供外源性输入。我们的假设是,颈性迷走神经增加了胃的适应能力,加速了胃的排空。我们的具体目的是比较左颈VNS激活前和激活后三个月对相同热量餐的胃排空和胃适应的同步评估。胃的功能将通过同时使用SPECT相机成像和放射性标记餐的验证方法进行测量,第一次测量静脉注射高铁酸盐后禁食期间的胃容量,第二次测量餐后胃容量调节和胃排空在摄入320千卡、30%脂肪蛋粉后。这些创新的研究将证明VNS的效果,为潜在的纠正胃运动功能障碍的新疗法奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL L. CAMILLERI其他文献
MICHAEL L. CAMILLERI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL L. CAMILLERI', 18)}}的其他基金
A randomized control trial of G-POEM for gastroparesis to assess feasibility, safety, efficacy and physiological mechanisms
G-POEM 治疗胃轻瘫的随机对照试验,旨在评估可行性、安全性、有效性和生理机制
- 批准号:
10843438 - 财政年份:2023
- 资助金额:
$ 7.58万 - 项目类别:
Parkinson Disease Neural Circuitry and Gastrointestinal Pathobiology
帕金森病神经回路和胃肠道病理学
- 批准号:
10740119 - 财政年份:2023
- 资助金额:
$ 7.58万 - 项目类别:
A randomized control trial of G-POEM for gastroparesis to assess feasibility, safety, efficacy and physiological mechanisms
G-POEM 治疗胃轻瘫的随机对照试验,旨在评估可行性、安全性、有效性和生理机制
- 批准号:
10416023 - 财政年份:2021
- 资助金额:
$ 7.58万 - 项目类别:
A randomized control trial of G-POEM for gastroparesis to assess feasibility, safety, efficacy and physiological mechanisms
G-POEM 治疗胃轻瘫的随机对照试验,旨在评估可行性、安全性、有效性和生理机制
- 批准号:
10211000 - 财政年份:2021
- 资助金额:
$ 7.58万 - 项目类别:
Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia
大麻二酚治疗胃轻瘫和功能性消化不良的药效学、药物遗传学、临床疗效和安全性
- 批准号:
9983012 - 财政年份:2019
- 资助金额:
$ 7.58万 - 项目类别:
Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia
大麻二酚治疗胃轻瘫和功能性消化不良的药效学、药物遗传学、临床疗效和安全性
- 批准号:
10404023 - 财政年份:2019
- 资助金额:
$ 7.58万 - 项目类别:
Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia
大麻二酚治疗胃轻瘫和功能性消化不良的药效学、药物遗传学、临床疗效和安全性
- 批准号:
9796963 - 财政年份:2019
- 资助金额:
$ 7.58万 - 项目类别:
Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia
大麻二酚治疗胃轻瘫和功能性消化不良的药效学、药物遗传学、临床疗效和安全性
- 批准号:
10165708 - 财政年份:2019
- 资助金额:
$ 7.58万 - 项目类别:
Bile Acids, Genetic Control and Colonic Function in Irritable Bowel Syndrome
胆汁酸、遗传控制和肠易激综合症的结肠功能
- 批准号:
8536669 - 财政年份:2011
- 资助金额:
$ 7.58万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 7.58万 - 项目类别:
Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 7.58万 - 项目类别:
Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 7.58万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 7.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 7.58万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 7.58万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 7.58万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 7.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 7.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 7.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




